Check out this morning’s top movers from around Wall Street, compiled by The Fly.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
HIGHER –
- Beneficient (BENF) up 84% after announcing that its subsidiary consummated a previously announced transaction pursuant to which approximately $126M of its preferred equity was redesignated as non-redeemable.
- SilverCrest Metals (SILV) up 10% after Coeur Mining (CDE) and the company announced that they have entered into a definitive agreement whereby, a wholly-owned subsidiary of Coeur will acquire all of the issued and outstanding shares of SilverCrest pursuant to a court-approved plan of arrangement
- Summit Therapeutics (SMMT) up 9% after completing enrollment in the Phase 3 HARMONi clinical trial evaluating ivonescimab plus platinum-doublet chemotherapy and also announcing that the FDA has granted Fast Track designation for the proposed use of the ivonescimab combination
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
LOWER –
- Spirit Airlines (SAVE) down 32% after The Wall Street Journal reported the company is in discussions with bondholders over the terms of a bankruptcy filing following the failed merger with JetBlue (JBLU)
- ZIM Integrated (ZIM) down 11% after WSJ reported dockworkers agreed to end a three-day strike after port employers offered a 62% increase in wages over six years
- Rivian Automotive (RIVN) down 6% after revising its annual production view due to experiencing a production disruption because of a shortage of a shared component on the R1 and RCV platforms
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JBLU: